Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Intellectual disability SUMOylation N K22 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome SUMOylation N K22 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Breast cancer Phosphorylation N S38 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S38 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Melanoma Phosphorylation N S38 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Acetylation N K129 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Acetylation N K129 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Methylation N K153 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung squamous cell carcinoma Methylation N K153 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Neurodevelopmental disorder Methylation N K153 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Renal cell carcinoma Methylation N K153 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N T164 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung squamous cell carcinoma Phosphorylation N T164 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N T171 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung squamous cell carcinoma Phosphorylation N T171 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K209 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Neurodevelopmental disorder Ubiquitination N K209 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Breast invasive carcinoma Acetylation N K219 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Acetylation N K219 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome SUMOylation N K234 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Head and neck squamous cell carcinoma Ubiquitination N K239 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K239 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K327 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Ubiquitination N K327 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Ubiquitination N K327 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S335 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Phosphorylation N S335 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S336 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Phosphorylation N S336 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S343 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S348 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S353 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N T372 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Intellectual disability Phosphorylation N S375 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S375 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Intellectual disability Phosphorylation N S383 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S383 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung squamous cell carcinoma Phosphorylation N S383 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Uterine corpus endometrial carcinoma Phosphorylation N S383 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S395 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Inborn genetic diseases Methylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Methylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Medulloblastoma Methylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Methylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Inborn genetic diseases SUMOylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome SUMOylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Medulloblastoma SUMOylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma SUMOylation N K432 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation C T433 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Inborn genetic diseases Phosphorylation N T433 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N T433 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Medulloblastoma Phosphorylation N T433 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Phosphorylation N T433 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Inborn genetic diseases Phosphorylation N S435 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S435 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Medulloblastoma Phosphorylation N S435 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Phosphorylation N S435 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Inborn genetic diseases Ubiquitination N K439 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K439 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Medulloblastoma Ubiquitination N K439 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Ubiquitination N K439 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Stomach adenocarcinoma Ubiquitination N K439 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S448 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Stomach adenocarcinoma Phosphorylation N S448 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome SUMOylation N K451 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Stomach adenocarcinoma SUMOylation N K451 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation C S460 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S460 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Bladder urothelial carcinoma Phosphorylation N S483 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S483 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Neurodevelopmental disorder Phosphorylation N S483 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Bladder urothelial carcinoma Phosphorylation N S497 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S497 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Hepatocellular carcinoma Phosphorylation N S556 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S556 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N Y560 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K568 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Adrenocortical carcinoma Ubiquitination N K638 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Adrenocortical carcinoma SUMOylation N K644 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome SUMOylation N K644 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Adrenocortical carcinoma Ubiquitination N K644 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K644 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N T652 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Sarcoma Phosphorylation N T652 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K659 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Sarcoma Ubiquitination N K659 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Phosphorylation C T708 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N T708 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Phosphorylation N T708 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Stomach adenocarcinoma Phosphorylation N T708 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Colon adenocarcinoma Phosphorylation N S729 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S729 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Phosphorylation N S729 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Colon adenocarcinoma Ubiquitination N K731 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K731 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Ubiquitination N K731 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Ubiquitination N K740 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Ubiquitination N K740 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Ubiquitination N K823 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Colon adenocarcinoma Ubiquitination N K827 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K827 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Skin cutaneous melanoma Ubiquitination N K827 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K890 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K895 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K968 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K968 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Methylation N R1002 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S1004 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Bladder urothelial carcinoma Phosphorylation N S1048 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Breast invasive carcinoma Phosphorylation N S1048 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S1048 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Breast adenocarcinoma Ubiquitination N K1086 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Ubiquitination N K1086 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Kleefstra syndrome Phosphorylation N S1276 Q9H9B1 79813 EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Lung adenocarcinoma Phosphorylation N S1276 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic kidney disease kidney tissue Butyrylation D K9 35909658 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic retinopathy ES cells Deacetylation D K9 29049850 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Cancer tumor tissues Propionylation A K23 32010779 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic retinopathy ES cells Deacetylation D K56 29049850 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Pancreatic ductal adenocarcinoma PDAC tissues Succinylation U K79 31610265 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Kleefstra syndrome Trimethylation U K9 29554304 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic nephropathy Dimethylation U K4 20067909 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i T-cell acute lymphoblastic leukemia Trimethylation U K4 22237151 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Duchenne muscular dystrophy Acetylation U K9 19264835 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Obesity Butyrylation D K9 33989779 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic nephropathy Dimethylation U K9 20067909 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i T-cell acute lymphoblastic leukemia Trimethylation U K9 22237151 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic nephropathy Serine phosphorylation U S10 20067909 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Duchenne muscular dystrophy Serine phosphorylation U S10 19264835 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Duchenne muscular dystrophy Acetylation U K14 19264835 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetes Butyrylation D K18 28450421 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Diabetic nephropathy Dimethylation U K23 20067909 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Syndromic intellectual disability Propionylation A K23 32010779 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Cardiomyopathy Propionylation U K23 37669116 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i T-cell acute lymphoblastic leukemia Trimethylation D K27 22237151 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Ataxia-telangiectasia Trimethylation U K27 24162653 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Alzheimer's disease Serine phosphorylation D S58 26199864 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Duchenne muscular dystrophy Acetylation U K79 19264835 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Leukemia Dimethylation U K79 23361907 P68433 31915 H3c1 H3a Hist1h3a; H3c8 H3.1-221 H3g Hist1h3g; H3c10 H3.1-291 H3h Hist1h3h; H3c11 H3.1-I H3i Hist1h3i Acute lymphocytic leukemia Lysine methylation U K79 18977325